This brand name is authorized in Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom, United States
The drug INCRUSE contains one active pharmaceutical ingredient (API):
|
1
Umeclidinium
UNII 7AN603V4JV - UMECLIDINIUM BROMIDE
|
|
Umeclidinium is a long acting muscarinic receptor antagonist (also referred to as an anticholinergic). It is a quinuclidine derivative that is a muscarinic receptor antagonist with activity across multiple muscarinic cholinergic receptor subtypes. Umeclidinium bromide exerts its bronchodilatory activity by competitively inhibiting the binding of acetylcholine with muscarinic cholinergic receptors on airway smooth muscle. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| INCRUSE ELLIPTA Inhalation powder, pre-dispensed | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03BB07 | R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10187E |
| Country: CA | Health Products and Food Branch | Identifier(s): 02423596 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 664-MEE-0115 |
| Country: EE | Ravimiamet | Identifier(s): 1646939, 1646940, 1646951 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 114922002 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 177512, 372536 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 68964304 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 275680, 374397, 376667, 379895, 381406 |
| Country: HK | Department of Health Drug Office | Identifier(s): 63954 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 61510 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 7556 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1073276, 1073277, 1073278 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 125318 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 17169 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100307439 |
| Country: SG | Health Sciences Authority | Identifier(s): 14853P |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 2883041 |
| Country: US | FDA, National Drug Code | Identifier(s): 0173-0873 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
